key: cord-0974951-4z73o69g
authors: Cho, Eunice; Rosa, Margarida; Anjum, Ruhi; Mehmood, Saman; Soban, Mariya; Mujtaba, Moniza; Bux, Khair; Dantu, Sarath; Pandini, Alessandro; Yin, Junqi; Ma, Heng; Ramanathan, Arvind; Islam, Barira; Mey, Antonia S J S; Bhowmik, Debsindhu; Haider, Shozeb
title: Structural dynamics of the β-coronavirus Mpro protease ligand binding sites
date: 2021-04-09
journal: bioRxiv
DOI: 10.1101/2021.03.31.437918
sha: 7b1eaac025b1fdabdb36bcf6918c5ac458dfd1b5
doc_id: 974951
cord_uid: 4z73o69g

β-coronaviruses alone have been responsible for three major global outbreaks in the 21st century. The current crisis has led to an urgent requirement to develop therapeutics. Even though a number of vaccines are available, alternative strategies targeting essential viral components are required as a back-up against the emergence of lethal viral variants. One such target is the main protease (Mpro) that plays an indispensible role in viral replication. The availability of over 270 Mpro X-ray structures in complex with inhibitors provides unique insights into ligand-protein interactions. Herein, we provide a comprehensive comparison of all non-redundant ligand-binding sites available for SARS-CoV2, SARS-CoV and MERS-CoV Mpro. Extensive adaptive sampling has been used to explore conformational dynamics employing convolutional variational auto encoder-based deep learning, and investigates structural conservation of the ligand binding sites using Markov state models across β-coronavirus homologs. Our results indicate that not all ligand-binding sites are dynamically conserved despite high sequence and structural conservation across β-coronavirus homologs. This highlights the complexity in targeting all three Mpro enzymes with a single pan inhibitor.

Coronaviruses (CoVs) belong to a family of positive-sense, single stranded RNA viruses with spherical envelope and a crown-like appearance due to their distinctive spike projections. 1, 2 While α or β-coronaviruses infect mammals, γ and δ-coronavirus can infect birds or mammals ( Figure 1A ). 3 Currently, seven CoVs have been identified that infect humans, namely human coronavirus 229E (HCoV-229E), OC43 (HCoV-OC43), NL63 (HCoV-NL63), Hong Kong University-1 (HCoV-HKU1), severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). 1, 2, [4] [5] [6] [7] [8] [9] The first four are responsible for 5-30% of the common cold, 10 while the latter three cause acute lung injury, acute respiratory distress syndrome, septic shock, and multi-organ failure with a high case fatality ratio. 1, 11 β-coronaviruses alone have been responsible for three major global outbreaks in the 21 st century: SARS in 2002, MERS in 2013 and COVID-19 in 2019, with a fatality rate of 10%, 34% and 3-5% respectively. 12 Coronavirus have the largest genome amongst any RNA viruses, with a size ranging between 26-32 kb. 13, 14 The replication cycle of CoVs is initiated by the spike protein attaching to the host receptor, inducing fusion events that allow viral entry into the host cell. 15 Once released inside, the viral genome is expressed into a series of proteins using multiple open reading frames (ORFs). In the SARS-CoV2 genome, 23 unannotated viral ORFs have been identified and include upstream ORFs that are likely to have a regulatory role; several in-frame internal ORFs within existing ORFs, resulting in N-terminally truncated products, as well as internal out-of-frame ORFs, which generate novel polypeptides. 16 Of these, two overlapping ORFs (ORF1a and ORF1b), which makes up of 2/3 rd of its genome, are translated into two large polyproteins (pp1a and pp1ab). The remaining genome is transcribed into conserved structural (spike, envelope, membrane and nucleocapsid) and accessory proteins that are not essential for virus replication but have a role in pathogenesis. 17 The pp1a and pp1ab are processed by two conserved viral proteases, 3-chymotrypsin-like cysteine protease (3CL pro or M pro ) and papain-like protease (PL pro ), into 16 non-structural proteins (Nsp1- 16) , which are essential for viral replication and transcription. 18 M pro is encoded by Nsp5 and auto-cleaved from polyproteins to produce a mature enzyme. The M pro enzyme then cleaves 11 downstream non-structural proteins important for viral replication, thereby making M pro an essential protein for the viral life cycle. 19 The substrate recognition sequence of M pro at most sites is x-(L/F/V)Q↓(G/A/S)-x (x = any amino acid; ↓ cleavage site), where the glutamine prior to cleavage site is essential. 20 No human protease with similar cleavage specificity is known. Thus compounds that target this cleavage site on M pro will have little or no impact on human cellular proteases. 21 This makes M pro an attractive drug target.

The SARS-CoV2 M pro structure is a homodimer, with each protomer (residues 1-306) composed of three domains ( Figure 1B ). Domain I (residues 8-101) consists of 6 β-strands (β 1-6) and one α-helix (α-helix A), while domain II (residues 102-184) consists of 6 β-strands (β 7-12). The β-strands form an antiparallel β-barrel structure in each domain and uses a long linker loop (residues 185-200) to connect to domain III (residues 201-303), which has five αhelices (α-helix B-F) arranged in a compact antiparallel globular cluster. 22 The substratebinding site is present in a cleft between domains I and II and buries the C145-H41 catalytic dyad. During the hydrolysis reaction, C145 acts as a nucleophile, while H41 acts as a base

catalyst. An oxyanion hole formed by the backbone amido groups of G143 and C145 stabilizes the partial negative charge developed at the substrate cleavage bond. 23 The substrate-binding site consists of four subsites (S1', S1, S2, S4) that define enzyme specificity for glutamine in the substrate. 22 Moreover, in the homodimer structure of the M pro enzyme, the N-finger (residues 1-7) of one protomer is squeezed between domain I and II to shape the substrate-specificity pocket. This shows the importance of dimerization and Nfinger orientation for substrate specificity and catalysis. 24 Further structural analysis of the SARS-CoV2 M pro identified that domain I and II are connected via seven residues (D92-P99) that contribute to the substrate-binding site. 21, 22 Domain III contributes to the proteolytic activity via dimerization of the M pro enzyme. 22 Dimerization is important because monomeric M pro does not exhibit any catalytic activity. 25 Since M pro is a symmetric homodimer, two copies of the ligand binding sites are present, one on each protomer.

A comparison of the SARS-CoV2, SARS-CoV and MERS-CoV M pro sequences revealed that SARS-CoV2 is 96% similar to SARS-CoV and 51% with MERS-CoV ( Figure S1 ). A structural superimposition of the all M pro enzymes displayed an overall RMSD of 0.85 Å (± 0.16 Å), with a very high degree of structural conservation around the catalytic dyad in the substrate-binding site, suggesting very similar substrate recognition profiles amongst these proteins ( Figure 1C) . The difference between SARS-CoV2 and SARS-CoV M pro is 12 amino acids in each protomer ( Figure 1D /E). These residues have been illustrated in Figure S2 .

The past year has seen a dramatic progress in SARS-CoV2 research (covid19primer.com).

Significant efforts have gone into the design of M pro inhibitors that target the substrate binding pocket. 21, 22, 26, 27 This also includes inhibitor design via various in silico methods. [28] [29] [30] [31] [32] [33] Recent progress on M pro inhibitors have been reviewed elsewhere. [34] [35] [36] Of considerable note is the COVID Moonshot project, which generates data via open science discovery of M pro inhibitors by combining crowdsourcing, high-throughput experiments, computational simulations and machine learning. 37 This alone has generated over 258 structures of fragment and lead-like molecules in complex with the M pro protease (www.covid.postera.ai/covid).

Other large-scale efforts using crystallographic screening of fragments and drug repurposing libraries have identified allosteric drug binding sites. 38, 39 Over 270 crystal structures of SARS-CoV2 M pro are present in the protein data bank (PDB), including apo and co-complexes with inhibitors (Table S1 ). Additional similar data is also available on SARS-CoV (Table S2) and MERS-CoV (Table S3 ) M pro enzymes. However, to date, no comprehensive, consolidated, comparison of ligand binding sites and their complexes determined using X-ray crystallography has been reported. In this study, we map non-redundant ligand binding sites from all crystal structures of SARS-CoV2 M pro available in the PDB. We then carry out 25 µs of adaptive molecular dynamics (MD) simulations on the apo M pro structure of SARS-CoV2, SARS-COV and MERS-CoV and explore the conformational dynamics of the M pro enzymes using a deep learning approach, namely a variational auto encoder with convolutional filters (CVAE), 40 and investigate the structural conservation of the ligand binding sites using Markov state models (MSM). Further, we annotate each binding site with a measure of correlated evolution at the residue level. Our results highlight that even though with a structural overlap of <1 Å, the conformational dynamics of SARS-CoV2, MERS-CoV and SARS-CoV are very different. A persistence analysis and comparison of the structural conservation of the ligand binding sites in βcoronavirus homologs highlight the complexity in targeting all three M pro enzymes with a single pan inhibitor.

The PDB was searched for β-coronavirus M pro entries. A total of 271 SARS-CoV2 structures were identified. Out of these, there are 38 structures with no ligands and were excluded from any further study. The remaining 233 structures were downloaded for detailed structural analysis and are listed in Table S1 -S6. The key interacting residues between the inhibitors and M pro were mapped ( Figure S3 ). In total, 22 different binding sites were identified. These have been labelled A-V in Figure 2 and listed in Table 1 . A detailed structural description of the binding site is provided in the supporting information.

To further understand the structural dynamics of the β-coronavirus M pro enzymes, MSMbased adaptive sampling molecular dynamics (MD) simulations were conducted. These simulations have an advantage over classical MD in exploring under sampled states without a predetermined bias. The sampling and analysis mainly focused on investigating the differences in dynamics of the M pro enzyme ligand binding sites. SARS-CoV2 and SARS-CoV are 96% identical, with a difference of only 24 residues out of 612. When structurally aligned, the root means squared deviation (RMSD) of the protein backbone aligned structures is 0.61 Å. This is also similar to when comparing with the MERS-CoV structure, where the sequence similarity is ~51% and the structural alignment is 0.51 Å.

The conformational drift during the course of the simulations was assessed using Cα root mean-squared deviation (RMSD). Conventional RMSD fitting methods fail to separate regions of different stability. To resolve such regions, we used a fraction (%) of the Cα atoms for the alignment. Beyond this fraction, there is a sharp increase in the RMSD value for the remainder of the Cα atoms. At 60%, the core of the M pro could be superimposed to less than 

CVAE can organize the conformational landscape in terms of a small number of biophysically relevant conformational coordinates from long timescale simulations. 40, 41 In protein folding trajectories, the CVAE-inferred reduced conformational coordinates correspond to separating folded and unfolded states (and potentially transitions involving these states) 40 and for equilibrium simulations, the CVAE provides biophysically relevant information related to conformational transitions induced by changes in hydrogenbonds/hydrophobic interactions. 41, 42 In this work, the CVAE was used to identify any differences in the collective conformational fluctuations within M pro simulations from SARS-CoV2, SARS-CoV and MERS-CoV.

First, the CVAE model quality from the simulation trajectories was evaluated by examining the training and validation loss for various models, with latent dimension size ranging from 3 to 11 ( Figure 6B ). Initially, as the dimension size increases, the corresponding model compresses less and hence has more representation capability. When the latent dimension becomes too large, the model may over fit local features and introduce extra noise, and the regularizing term (Kullback-Leibler divergence) of the loss will play a bigger role. The overall loss approaches an optimal value in between those two extremes. For this dataset, the CVAE model is quite stable and robust, considering the validation loss stays close across various latent dimensions.

A latent dimension of 7 was selected based on the reconstruction loss as well as the uncertainty in the validation set. Next, t-distributed stochastic neighbor embedding (t-sne) was performed on this compressed lower-dimension data to visualize in two dimensions. 40 Figure 3A shows the two-dimensional t-sne representation of the CVAE low-dimension data, while Figure 3B depicts three dimensions of the compression CVAE low-dimensional data.

The CVAE is able to completely cluster the three different β-coronavirus M pro types based on the local and global conformational dynamics ( Figure 3 ). This is more visible in the twodimensional representation. Here, SARS-CoV2 and SARS-CoV behave similar to each other while MERS-CoV is very different. One must note that this clustering is not evident when using traditional features (such as RMSD or native contacts) to distinguish among these three types of closely related β-coronavirus homologs, proving the sensitivity of the CVAE implementation.

The main focus for building an MSM was to investigate how the various binding sites identified from X-ray crystallography (Table 1-3) were linked dynamically in the network of metastable states and transition probabilities among them. The choice of this method was based on the ability of MSM methods to use large ensembles of short-timescale trajectories for sampling events that occur on slow timescales. 43, 44 The metastable states are an ensemble of structural conformations that interconvert quickly within the ensemble and slowly between them. These ensembles broadly correspond to the different basins on the free energy landscape (FEL). MSMs, provide a powerful method for detecting metastable states, calculating kinetics and free energies by integrating any number of simulations into a single statistical model. [43] [44] [45] [46] [47] [48] We first used φ and ψ dihedral angles of the 24 residues that are dissimilar between SARS-CoV2 and SARS-CoV ( Figure S2 ) as input data. However, this data was not sufficient to build a converged MSM. We then included φ and ψ dihedral angles of all residues and χ1

angle from the 24 residues that were different as input data to construct MSM. The dimensionality of the data was further reduced through time-independent component analysis 

Since many of the ligand binding sites appears together on the M pro surface, we investigated the spatiotemporal evolution of the binding pockets. Protein conformations of the metastable states were searched for the presence of the experimentally reported binding sites. The site

was described as open, if it could hold a minimum of five water molecules, which was a coarse equivalent of a small fragment. A comparison of equivalence was then made between the sites identified from the simulation data and those from crystallographic experiments. A comprehensive list of the binding sites and their persistence across metastable states identified from SARS-CoV2, SARS-CoV and MERS-CoV M pro dynamics is presented in Table 4 . is free to rotate and can adopt a conformation that can occupy the empty binding site ( Figure   5A ). Furthermore, the C-terminal tail also occludes one of the binding sites in state 2, and 3.

Site N is a deep cleft between α-helix D and F and is spatially positioned adjacent to site M.

The side chain of F294 (α-helix F) is shared between both the sites. The rotation of the phenyl side chain controls the opening and closure of site N. When site N is open, the phenyl side chain of F294 is positioned on α-helix F. In the closed state, the F294 side chain is positioned in the cleft. This conformation is analogous to that observed when a ligand is bound to site M. Site N is also conjoined with another larger cavity that runs orthogonal to it.

When the ligand binds to this pocket (as in PDB 7AGA), the conformation of the side chain of F294 is similar to that observed in site M, which occludes site N. We observe all these conformations of F294 in our metastable states. The N site is present in both protomers in state 1; and in one of the two protomers in state 2, 3, 4 and 5. The orthogonal site is present in conjunction with site N in at least one of the protomers ( Figure 5B ).

Site O is a pseudo-ligand binding site on the loop between α-helix E and F. When bound, the ligand is completely solvent exposed and interacts with protein structure by making hydrogen bonds with the side chains of N277 and R279. These interactions stabilise the flexibility of this loop. In the simulated apo structure, when the ligand is absent, this loop is highly mobile and the side chains of N277 and R279 display enhanced flexibility ( Figure 5C ). This results in the loss of the conformation of the loop to which the ligand binds. The conformation of the loop, similar to that adopted in the representative structure is not observed in any metastable state.

Site Q at the interface between the two protomers is spatially positioned between the distal ends of α-helices B, D and F. At the end of α-helix F is a short C-terminal tail (residues 300-306). In the representative crystal structure (PDB 7AMJ), the tail orients away from the α- binding site Q and would prevent any ligand binding ( Figure 5D ). This conformation is similar to that observed in PDB 6LU7 structure. Site Q is present between one interface in states 3, 4; completely occluded in states 1, 2 and is present at both interfaces in state 5.

In the representative structure of site T (PDB 7KVL), the fragment makes hydrogen bonds with the hydroxyl group of Y237 (α-helix C) and the side chain of K269 (α-helix E). In the apo simulation, when the ligand is absent, the side chain of these residues can occupy the space where the fragment binds ( Figure 5E ). This results in the loss of this site in states 1, 2, and 5. However, the site is present in both protomers in state 4 and in only one protomer in state 3.

Site U is a solvent exposed pseudo-ligand binding site that is stabilised by the hydrogen bond interaction between the side chains of K88 and Q83. A part of this binding site is formed by N84, present in the loop between β5-β6 strands. In the absence of the fragment, the residues from this site can adopt multiple conformations, which would be unsuitable for stacking of any fragment in this site ( Figure 5F ). The conformation of residues comparable to the representative site is present in both protomers in states 1, 3; and in one protomer in 2, 4 and 5.

In SARS-CoV, sites equivalent to A-F, H-J, P, R, S and V are present in all metastable states.

These sites are well-defined pockets and are comparable to the X-ray crystal structures of SARS-CoV2 (Table 4) .

Site G, which is formed at the interface of the two protomers is lost in all metastable states of SARS-CoV. During the dynamics of the apo state, the loop between β8-β9 becomes flexible.

The mobility of the loop pushes the N-finger, tucked below the substrate binding A site to collapse on site G ( Figure 5G ). In this conformation, no ligand would be able to bind to this site.

Binding site K is also lost in all metastable states in SARS-CoV. In this site, the hydroxyl Our detailed structural dynamics analysis highlights the importance of the dynamic conservation of ligand binding sites across β-coronavirus homologs. Based on these observations we emphasize that ligand design should be preferred on target binding sites that are not only structural but also dynamically conserved across all β-coronavirus homologs.

The past 20 years has seen outbreaks caused by three highly pathogenic β-coronavirus 

The protein data bank in Europe knowledge base (PDBe-KB) was searched with the key word "3C-like proteinase" and selecting "Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)" as the organism. The PDB codes were noted and the structural coordinates representative ligand binding site data has been tabulated in Table 1 -3.

The coordinates of the apo structure of the SARS-CoV2 (PDB 6LU7), 22 framework. 60, 61 The charges were assigned after optimisation of the hydrogen-bonding network in the protonated structure. 61 The catalytic cysteine residue was set to a reduced state. The Amber ff14SB force field was used to describe the protein. 62 Each system was solvated using TIP3P water in a cubic box, the edge of which was set to at least 10 Å from the closest solute atom. 63 Counter ions were added to neutralise the system. The simulation protocol was identical for each system. The systems were minimized and relaxed under NPT conditions for 50 ns at 1 atm. The temperature was increased to 300 K using a time step of 4 fs, rigid bonds, cut off of 9.0 Å and particle mesh Ewald summations switched on for longrange electrostatics. 64 During the equilibration step, the protein's backbone were restrained by a spring constant set at 1 kcal mol -1 Å -2 , while the ions and solvent were free to move. The production simulations were run in the NVT ensemble using a Langevin thermostat with a damping constant of 0.1 ps and hydrogen mass repartitioning scheme to achieve a time step of 4 fs. 65 The final production step was run as Adaptive Sampling, without any restraints, as multiple iterations of short parallel simulations as implemented in HTMD framework. 

Markov state models (MSMs) were constructed to provide kinetics and free energy estimates.

The MSM was built using the PyEMMA v2.5.7 program. 67 It was not possible to build an MSM using just the features of the 24 dissimilar residues (12 in each protomer) between SARS-CoV2 and SARS-CoV. Therefore, all backbone dihedral angles were selected. In addition, the first χ angle (χ1) from 24 dissimilar residues were also included in MSM building. For MERS-CoV, χ1 angles from residues at equivalent position were also selected.

Time-lagged independent component analysis (tICA) was used to reduce the dimensionality of the data. 68, 69 It was possible to build models that were Markovian with a lag time of ≥10, with the lag time being selected according to the convergence of the implied timescales. The dimension reduction was achieved by projecting on the three slowest tICA components. The K-means clustering algorithm was used to obtain 100 microstates. The conformational clusters were grouped together based on kinetic similarity using the PCCA+ algorithm. 70 The 

The Convolutional Variational Autoencoder or CVAE was used for analysis, 40 which has been optimized for large scale systems on HPC platform. 71 The implementation of CVAE has been previously shown to provide meaningful insights to diverse systems such as protein folding, 72 enzyme dynamics, 41, 73 Coronavirus spike protein 74 and Coronavirus non-structured proteins. 75 A CVAE consists of a variational autoencoder along with multiple convolutional layers.

Generally, the autoencoder (AE) has an hourglass type of shape where high dimensional data goes into as input and the AE captures only the essential information required to represent the original input data. This compressed latent representation is then used to reconstruct the data back to the original format ensuring no loss of information during the compression phase.

The clustering and reconstruction quality of the CVAE, the training procedure was repeated for various latent dimension sizes and to identify the best model for the dataset ( Figure 6B ). The loss over the epochs is as expected (i.e., without over fitting or any other unusual behavior) and shown in Figure 6C . Finally, the original input data was compared with the predicted (i.e., decompressed) data to ensure no loss of information during the compression process through the latent space ( Figure 6D ).

Pocketron was used to detect small molecule binding sites using default values. 76 The metastable states were screened for pockets, which were classified as open if they could accommodate at least 5 water molecules (coarse equivalent of a small fragment). Each representative binding pocket, identified from the crystal structures, was compared by superimposition with the metastable state from each system.

Pairwise evolutionary constraints were estimated from a multiple sequence alignment (MSA).

The FASTA sequence from the SARS-CoV2 M pro (PDB 6LU7) was selected as reference and the MSA was built using hhsuite3. 77 Pairwise correlations were calculated using ccmpred package 78 as per the parameters described in Akere et al. 73 Raw correlation scores (C i ) were then scaled as per Kamisetty et al. 79 For all 22 pockets (see Table 1 ), the scaled pairwise correlation matrix was used to estimate the evolutionary conservation score (E a ) of each pocket (Eq 1), where N is the number of residues in the pocket.

The score estimates the evolutionary constraints on the pocket as an average of the pairwise correlation in the pocket. For reference, scores were compared with the median and standard deviation of C i for all surface residue pairs ( Figure S10 ). Surface residues were defined as having > 50% relative accessible surface area. 80, 81 Data Availability Statement 

The supporting information is available free of charge at .. representation. Original high dimensional data is transformed into distance matrix format, which is then fed to CVAE architecture. The CVAE captures the intrinsic features of the high dimensional data that are necessary to describe the original system behavior. This captured information is then shown into three-dimensional format (right) and in two-dimensional format (left) following t-sne treatment. The results show that MERS-CoV (green) dynamics is very different from SARS-CoV (red) or SARS-CoV2 (blue). 

Forty Years with Coronaviruses

Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus

A New Virus Isolated from the Human Respiratory Tract

Recovery in Tracheal Organ Cultures of Novel Viruses from Patients with Respiratory Disease

Detection of the New Human Coronavirus HKU1: A Report of 6 Cases

Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies

An Overview of Their Replication and Pathogenesis

Recent Insights into Emerging Coronaviruses

Update on Human Rhinovirus and Coronavirus Infections

Lower Respiratory Tract Infection in the Community: Associations between Viral Aetiology and Illness Course

Comparing SARS-CoV-2 with SARS-CoV and Influenza Pandemics. The Lancet Infectious Diseases

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

The Molecular Biology of Coronaviruses

Coronavirus Biology and Replication: Implications for SARS-CoV-2

The Coding Capacity of SARS-CoV-2

Characterization of Accessory Genes in Coronavirus Genomes

The SARS-CoV-2 Main Protease as Drug Target

Crystallographic Studies on Coronaviral Proteases Enable Antiviral Drug Design

SARS-CoV-2 M pro Inhibitors and Activity-Based Probes for Patient-Sample Imaging

Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved α-Ketoamide Inhibitors

Structure of M pro from SARS-CoV-2 and Discovery of Its Inhibitors

Evidence for Substrate Binding-Induced Zwitterion Formation in the Catalytic Cys-His Dyad of the SARS-CoV Main Protease

Critical Assessment of Important Regions in the Subunit Association and Catalytic Action of the Severe Acute Respiratory Syndrome Coronavirus Main Protease

Activation and Maturation of SARS-CoV Main Protease

Structural Basis for the Inhibition of SARS-CoV-2 Main Protease by Antineoplastic Drug Carmofur

Prediction of the SARS-CoV-2 (2019-NCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates

Drug Repurposing for Coronavirus (COVID-19): In Silico Screening of Known Drugs against Coronavirus 3CL Hydrolase and Protease Enzymes

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2

Large-Scale Ligand-Based Virtual Screening for SARS-CoV-2 Inhibitors Using Deep Neural Networks; SSRN Scholarly Paper ID 3561442

Virtual Screening and Repurposing of FDA Approved Drugs against COVID-19 Main Protease

Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds

Potential SARS-CoV-2 Main Protease Inhibitors. Drug Discovery Today 2020

Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

Open Science Discovery of SARS-CoV-2 Main Protease Inhibitors by Combining Crowdsourcing, High-Throughput Experiments, Computational Simulations, and Machine Learning. bioRxiv 2020

Crystallographic and Electrophilic Fragment Screening of the SARS-CoV-2 Main Protease

Deep Clustering of Protein Folding Simulations

Mechanism of Glucocerebrosidase Activation and Dysfunction in Gaucher Disease Unraveled by Molecular Dynamics and Deep Learning

Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics; preprint

State Models Provide Insights into Dynamic Modulation of Protein Function

Dynamic Design: Manipulation of Millisecond Timescale Motions on the Energy Landscape of Cyclophilin A

Complete Reconstruction of an Enzyme-Inhibitor Binding Process by Molecular Dynamics Simulations

Protein Conformational Plasticity and Complex Ligand-Binding Kinetics Explored by Atomistic Simulations and Markov Models

Markov Models of Molecular Kinetics

Markov State Models Can and Cannot Do: Correlation versus Path-Based Observables in Protein Folding Models

The Catalysis of the SARS 3C-like Protease Is under Extensive Regulation by Its Extra Domain

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations

SARS-CoV-2 Main Protease: A Molecular Dynamics Study

Probing the Dynamic Structure-Function and Structure-Free Energy Relationships of the Coronavirus Main Protease with Biodynamics Theory

Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Protease

Computational Analysis of Dynamic Allostery and Control in the SARS-CoV-2 Main Protease

From SARS and MERS to COVID-19: A Brief Summary and Comparison of Severe Acute Respiratory Infections Caused by Three Highly Pathogenic Human Coronaviruses

The Protein Imager: A Full-Featured Online Molecular Viewer Interface with Server-Side HQ-Rendering Capabilities

Structure of the SARS Coronavirus Main Proteinase as an Active C 2 Crystallographic Dimer

Ligand-Induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus Nsp5 Protease (3CLpro)

HTMD: High-Throughput Molecular Dynamics for Molecular Discovery

PlayMolecule ProteinPrepare: A Web Application for Protein Preparation for Molecular Dynamics Simulations

Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff99SB

Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K

A Smooth Particle Mesh Ewald Method

Improving Efficiency of Large Time-scale Molecular Dynamics Simulations of Hydrogen-rich Systems

VMD: Visual Molecular Dynamics

PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models

Identification of Slow Molecular Order Parameters for Markov Model Construction

Improvements in Markov State Model Construction Reveal Many Non-Native Interactions in the Folding of NTL9

Robust Perron Cluster Analysis in Conformation Dynamics

Towards Native Execution of Deep Learning on a Leadership-Class HPC System

DeepDriveMD: Deep-Learning Driven Adaptive Molecular Simulations for Protein Folding

Structure-Based Enzyme Engineering Improves Donor-Substrate Recognition of Arabidopsis Thaliana Glycosyltransferases

Distinct Structural Flexibility within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets

BiKi Life Sciences: A New Suite for Molecular Dynamics and Related Methods in Drug Discovery

HH-Suite3 for Fast Remote Homology Detection and Deep Protein Annotation

Learning Generative Models for Protein Fold Families

Assessing the Utility of Coevolution-Based Residue-Residue Contact Predictions in a Sequence-and Structure-Rich Era

Dictionary of Protein Secondary Structure: Pattern Recognition of Hydrogen-Bonded and Geometrical Features

Maximum Allowed Solvent Accessibilites of Residues in Proteins

Accelerating Scientific Discovery

The authors declare no potential conflict of interest

The authors would like to thank the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim (http://hecbiosim.ac.uk) for time to run simulations on ARCHER.BI would like to acknowledge the COVID-19 pump-priming grant from the University of Huddersfield for funding computing resources for analysis. SH would like to thank Prof